| pubmed-article:8965166 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8965166 | lifeskim:mentions | umls-concept:C0010654 | lld:lifeskim |
| pubmed-article:8965166 | lifeskim:mentions | umls-concept:C1883036 | lld:lifeskim |
| pubmed-article:8965166 | lifeskim:mentions | umls-concept:C0303611 | lld:lifeskim |
| pubmed-article:8965166 | lifeskim:mentions | umls-concept:C2347885 | lld:lifeskim |
| pubmed-article:8965166 | lifeskim:mentions | umls-concept:C1707271 | lld:lifeskim |
| pubmed-article:8965166 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8965166 | pubmed:dateCreated | 1996-12-11 | lld:pubmed |
| pubmed-article:8965166 | pubmed:abstractText | Single-chain Fv (scFv) antibody fragments have potential for clinical imaging because of their rapid tumor penetration and high tumor-to-tissue ratios at early time points. ScFvs clear rapidly from the circulation so radiolabels such as 99mTc which have short half-lives are desirable, but the free thiol groups necessary for labeling with 99mTc are not normally found on these molecules. | lld:pubmed |
| pubmed-article:8965166 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8965166 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8965166 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8965166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8965166 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8965166 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8965166 | pubmed:month | May | lld:pubmed |
| pubmed-article:8965166 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:CaseyJ LJL | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:KeenP GPG | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:BegentR HRH | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:RobsonLL | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:HawkinsR ERE | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:ChesterK AKA | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:BodenJ AJA | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:PedleyBB | lld:pubmed |
| pubmed-article:8965166 | pubmed:author | pubmed-author:VerhaarM JMJ | lld:pubmed |
| pubmed-article:8965166 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8965166 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:8965166 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8965166 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8965166 | pubmed:pagination | 868-72 | lld:pubmed |
| pubmed-article:8965166 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:meshHeading | pubmed-meshheading:8965166-... | lld:pubmed |
| pubmed-article:8965166 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8965166 | pubmed:articleTitle | Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine. | lld:pubmed |
| pubmed-article:8965166 | pubmed:affiliation | CRC Laboratories, Department of Clinical Oncology, Royal Free Hospital School of Medicine, London, United Kingdom. | lld:pubmed |
| pubmed-article:8965166 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8965166 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8965166 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8965166 | lld:pubmed |
